Metraipolis › archive › dc_beb7181f3d76
Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41010765
- DOI
- 10.3390/jcm14186561
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:26:01.762Z
- SHA-256 of the archived text
2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d- Stable URL of this page
https://metraipolis.com/documento/dc_beb7181f3d76
How to cite
Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765 — Europe PMC (en), https://europepmc.org/article/MED/41010765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb7181f3d76 (Metraipolis archive dc_beb7181f3d76, sha256 2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d)
BibTeX
@misc{dcbeb7181f3d76,
title = {Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41010765},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb7181f3d76; sha256 2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010765. Agents can read the archived copy with the MCP tool read_document.